• Rescind the Recombinant DNA Use and Technology Regulation,
• Remove the prohibition on rDNA research on BSL-4 agents in Boston, under the condition that any rDNA project undergo rigorous approval process for BSL-4 projects
• Incorporate the regulation of the use of recombinant DNA (rDNA) into the Biological Lab Regulation,
• Formalize a requirement that each individual BSL-4 research project undergo review by the Boston Biosafety Committee prior to receiving approval by BPHC, and
• Revise definitions and citations to align with updated national guidance documents.

Board meeting materials can be found here.

Current Regulations

Biological Laboratory Regulation Guidelines (Subject to ongoing revision)